Table 4.
Variable | Sensitivity | Specificity | AUC (95%CI) | P value |
---|---|---|---|---|
Original cohort | ||||
PAR | 60.3 | 74.3 | 0.726 (0.714–0.739) | |
NLR | 12.3 | 90.8 | 0.504 (0.486–0.519) | < 0.001 |
PLR | 37.5 | 76.6 | 0.603 (0.589–0.616) | < 0.001 |
MLR | 28.2 | 74.3 | 0.501 (0.488–0.515) | < 0.001 |
SII | 43.4 | 79.5 | 0.615 (0.601–0.628) | 0.004 |
Validation cohort | ||||
PAR | 70.7 | 69.7 | 0.744 (0.722–0.766) | |
NLR | 48.3 | 56.4 | 0.507 (0.485–0.529) | < 0.001 |
PLR | 80.4 | 28.6 | 0.602 (0.580–0.624) | < 0.001 |
MLR | 54.0 | 48.6 | 0.503 (0.481–0.525) | < 0.001 |
SII | 49.3 | 62.2 | 0.507 (0.485–0.529) | < 0.001 |
PAR, platelet to serum albumin ratio, NLR, neutrophil-lymphocyte ratio, PLR, platelet-lymphocyte ratio, MLR, monocyte-lymphocyte ratio, SII, systemic immune-inflammation index, area under the receiver operating curve